Sponsor:
Lakshmi N Yatham
Code:
NCT06943573
Conditions
Bipolar II Depression
Eligibility Criteria
Sex: All
Age: 19 - 65
Healthy Volunteers: Not accepted
Interventions
psilocybin (25 mg)
psilocybin 1mg micro-dose
Brief summary:
Conditions
Bipolar II Depression
Study ID
NCT06943573
Start date
Jun 15, 2026
Status verified date
Aug, 2026
Completion date
Dec, 2028
Anticipated
Primary completion date
Dec, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 19 - 65
Healthy Volunteers: Not accepted
Enrollment
90 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Active
placebo comparator: Placebo
Interventions
psilocybin (25 mg)
psilocybin 1mg micro-dose
Primary outcome measure
Central contacts
Locations
Djavad Mowafaghian Centre for Brain Health
Recruiting
Vancouver, British Columbia, Canada, V6T 1Z3
Contacts
Principal Investigator:
Lakshmi N Yatham, MBBS, FRCPC, MRCPsych, MBA
Sponsor
Lakshmi N Yatham
Last update posted
Sep 15, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-16. This information was provided to ClinicalTrials.gov by Lakshmi N Yatham on 2026-09-15.